Changes in Ownership

Cytek Biosciences, Inc. Filed 2022-03-16 Acc 0001104659-22-034568

Director bought 583,870 shares at an average $12.31 ($7,188,926)

From the SEC's structured data for this filing

Trades in this filing

Insider	Date	Transaction	Shares	Price	Value	Owned after	D/I
RA CAPITAL MANAGEMENT, L.P. Director	2022-03-14	Purchase	+342,143	$12.35	$4,223,926	13,139,327	I
RA CAPITAL MANAGEMENT, L.P. Director	2022-03-15	Purchase	+241,727	$12.27	$2,964,999	13,381,054	I
Open-market purchases · 583,870 sh · avg $12.31 · $7,188,926